11.10
Neogenomics Inc (NEO) 最新ニュース
NeoGenomics plummets on Q4 2024 bottom line miss, soft EPS guidance - MSN
Bank of America Issues Pessimistic Forecast for NeoGenomics (NASDAQ:NEO) Stock Price - MarketBeat
NeoGenomics (NASDAQ:NEO) Price Target Cut to $18.00 by Analysts at Needham & Company LLC - MarketBeat
NeoGenomics Schedules its Third Quarter 2021, Earnings Release for November 4, 2021 - ACCESS Newswire
BTIG cuts Neogenomics price target to $17, maintains Buy rating - Investing.com India
BTIG cuts Neogenomics price target to $17, maintains Buy rating By Investing.com - Investing.com Canada
NeoGenomics, Inc. (NASDAQ:NEO) Q4 2024 Earnings Call Transcript - MSN
NeoGenomics (NASDAQ:NEO) Sets New 52-Week Low After Earnings Miss - MarketBeat
Morgan Stanley cuts Neogenomics stock target to $17 from $18 By Investing.com - Investing.com Canada
NeoGenomics (NASDAQ:NEO) Posts Quarterly Earnings Results, Misses Expectations By $0.05 EPS - MarketBeat
NeoGenomics price target lowered to $19 from $20 at TD Cowen - TipRanks
NeoGenomics (NASDAQ:NEO) Issues Earnings Results - MarketBeat
NeoGenomics targets 1M patients annually by 2028 with 11%-13% revenue growth in 2025 - MSN
Demystifying NeoGenomics: Insights From 6 Analyst Reviews - Benzinga
NeoGenomics Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance
NeoGenomics: Q4 Earnings Snapshot - CT Insider
NeoGenomics Inc (NEO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Parp Inhibitor Biomarkers Market Future Business - openPR
NeoGenomics Achieves Double-Digit Revenue Growth in 2024 - TipRanks
Raymond James holds Neogenomics at Market Perform By Investing.com - Investing.com Nigeria
NeoGenomics Q4 Earnings Call Highlights Growth Amid Challenges - TipRanks
NeoGenomics Quarterly Results: Shares Plummet Amidst Financial ConcernsNews and Statistics - IndexBox, Inc.
Why NeoGenomics (NEO) Shares Are Trading Lower Today - The Globe and Mail
Why NeoGenomics (NEO) Shares Are Trading Lower Today By Stock Story - Investing.com Canada
NeoGenomics stock tumbles on weak EPS guidance By Investing.com - Investing.com Nigeria
Trend Tracker for (NEO) - Stock Traders Daily
NeoGenomics (NEO) Tops Q4 Earnings Estimates - MSN
Earnings call transcript: NeoGenomics Q4 2024 earnings beat expectations, stock drops - Investing.com
NeoGenomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 - Marketscreener.com
Raymond James holds Neogenomics at Market Perform - Investing.com India
Neogenomics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Here's Why NeoGenomics (NASDAQ:NEO) Can Afford Some Debt - Simply Wall St
NeoGenomics reports Q4 adjusted EPS 4c, consensus 3c - TipRanks
NeoGenomics Reports Fourth Quarter and Full Year 2024 Results - BioSpace
NEOGENOMICS Earnings Results: $NEO Reports Quarterly Earnings - Nasdaq
Earnings Flash (NEO) NeoGenomics Posts Q4 Revenue $172M, vs. FactSet Est of $173.2M - Marketscreener.com
Neogenomics Inc Reaffirms Full-Year 2025 Guidance -February 18, 2025 at 07:19 am EST - Marketscreener.com
NeoGenomics (NASDAQ:NEO) Misses Q4 Sales Targets - Yahoo Finance
Not Just a DEX: How Pineapple’s Mystery Marketing is Changing the Game - GlobeNewswire Inc.
NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect - MSN
NeoGenomics Set to Surpass Revenue Growth ProjectionsNews and Statistics - IndexBox, Inc.
Brokerages Set NeoGenomics, Inc. (NASDAQ:NEO) Target Price at $20.20 - MarketBeat
NeoGenomics (NEO) Projected to Post Earnings on Tuesday - MarketBeat
NeoGenomics Q4 2024 Earnings Preview - MSN
NeoGenomics Reports 9% Revenue Growth to $116 Million in the First Quarter - ACCESS Newswire
NeoGenomics To Participate In The Stephens Annual Investment Conference 2021 - ACCESS Newswire
NeoGenomics Enters Strategic Collaboration with Inivata to Commercialize InVisionFirst(R)-Lung Liquid Biopsy Test - ACCESS Newswire
NeoGenomics Appoints David Perez, Industry Veteran and Former Terumo BCT CEO, to Its Board of Directors - ACCESS Newswire
大文字化:
|
ボリューム (24 時間):